New York, NY – Investors in TransMedics Group, Inc., a company traded under NASDAQ with the ticker symbol TMDX, have been alerted to a class action lawsuit spearheaded by the law firm Levi & Korsinsky, LLP. This legal action is focused on claims of alleged securities fraud affecting shareholders between February 28, 2023, and January 10, 2025.
The lawsuit alleges that TransMedics was involved in various unethical and illegal practices to buoy its business and financial numbers, including the use of kickbacks and coercive tactics. There are also allegations of fraudulent overbilling and a general absence of safety oversight, which according to the filed complaint, concealed significant safety issues.
These actions purportedly exposed TransMedics to a higher degree of regulatory scrutiny, putting the company at a substantial risk which, the lawsuit claims, was not properly disclosed to the investors. As such, the statements made by TransMedics concerning its operations and business prospects were allegedly misleading, lacking a reasonable foundation during the stated period.
Shareholders who suffered financial losses during this timeframe have until April 15, 2025, to apply for the position of lead plaintiff in the class action suit. However, it is important to note that potential recovery does not require that one serve as a lead plaintiff to participate in any financial settlements that might result.
Participation in the class action will not incur any out-of-pocket costs or fees for the class members. Levi & Korsinsky is handling the lawsuit on a contingency basis, meaning fees are only recovered if the lawsuit is successful.
With a track record extending over two decades, Levi & Korsinsky holds a reputation for securing substantial settlements in favor of aggrieved shareholders in complex securities litigation. The firm has consistently been ranked among the top litigation firms in the U.S., solidifying its standing with a robust team capable of managing and winning significant legal battles.
For more details or to participate in this class action, TransMedics shareholders may contact Joseph E. Levi, Esq. by email at [email protected] or by telephone at (212) 363-7500.
Firms like Levi & Korsinsky play a pivotal role in the securities law landscape, ensuring accountability and transparency within public trading entities, thereby safeguarding investor interests.
Disclaimer: This article was automatically generated by Open AI, and the information regarding people, facts, circumstances, and stories may be inaccurate. Requests for article removal, retraction, or correction can be directed to [email protected]